Paola Valsasina1, Maria Assunta Rocca1, Fiammetta Pirro1, Elisabetta Pagani1, Alessandro Meani1, Massimiliano Copetti2, Filippo Martinelli Boneschi3, Vittorio Martinelli3, Giancarlo Comi3, Andrea Falini4, and Massimo Filippi1
1Neuroimaging Research Unit, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy, 2IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy, 3Department of Neurology, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy, 4Department of Neuroradiology, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy
Synopsis
Aim of this study was to identify the MRI predictors of medium-term disability and cognitive
impairment accrual in patients with the main clinical phenotypes of multiple
sclerosis (MS). Results indicated that clinical disability and cognitive impairment
at follow-up were predicted by measures of structural and microstructural
damage, as well as by resting state functional connectivity measures. Preserved
white matter integrity predicted clinical improvement. Grey matter involvement
played a critical role in MS-related clinical worsening and evolution to a more
severe disease phenotype.
Purpose
Conventional
MRI (cMRI) measures have a prognostic role in patients
with a clinically isolated syndrome [1], while their role in patients with
definite multiple sclerosis (MS) is still debated, with recent evidences
suggesting that grey matter atrophy is better associated with long term
disability and cognitive impairment than focal white matter lesions [2]. Aim of
this study was to assess the value of conventional MRI, diffusion
tensor imaging (DTI) and resting state (RS) functional connectivity (FC) MRI
measures in predicting clinical deterioration and cognitive impairment over a
four-year follow-up (FU) in patients with MS.Methods
Using a 3T Philips
scanner, dual-echo, 3D T1-weighted, DT and RS functional MRI scans were
obtained at baseline from 248 right-handed MS patients and 98 matched healthy
controls. Patients underwent a
neurologic and neuropsychological evaluation at baseline and after a median period
of 3.8 years of FU. Based on Expanded Disability Status Scale score [3]
modifications at follow-up, MS patients were classified as clinically stable, worsened or improved. Patients
were defined as cognitively worsened if the number of cognitive tests failed
was greater than at baseline. Average fractional anisotropy (FA) and mean
diffusivity (MD) values from the 48 white
matter regions of the ICBM-DTI-81 white-matter label atlas [4] were obtained. The main sensory, motor and
cognitive RS FC networks were identified using independent component analysis [5]
with calculation of global and regional differences. Multivariate logistic predictive models were built using clinical
worsening, evolution to a more severe clinical phenotype, clinical improvement
and cognitive deterioration as dependent variables.Results
At follow-up, 35% of the
patients had clinically worsened, 6% had clinically improved and 27% had
cognitively worsened. Patients divided according to follow-up clinical or
cognitive status, showed several statistically significant differences in
lesional and atrophy measures, DT MRI and RS FC measures at baseline. Figure
1 shows the results of Random Forest analysis, which detected the ten most
important MRI variables correlated with each clinical outcome. The multivariate
analysis showed that lower grey matter volume and lower default mode network RS
FC best predicted clinical worsening (C-index=0.67) and evolution to a more
severe clinical phenotype. Higher thalamic network RS FC predicted a worsened
clinical and cognitive status, probably indicating a maladaptive response. A
higher fractional anisotropy in the normal-appearing white matter predicted
clinical improvement (C-index=0.71). Both microstructural damage in the corpus
callosum and lower executive control network RS FC predicted cognitive
deterioration (C-index=0.84). Conclusions
Advanced MRI techniques are an
essential tool to improve our understanding of the extreme variability in MS
and allow prognosis prediction at an individual level.Acknowledgements
This study was partially supported
by a grant from FISM 2014/R/7.References
[1] Giorgio A., et
al., Neurology 2013; 80:234-41.
[2] Filippi M., et al. Neurology
2013; 81:1759-67.
[3] Kurtzke J.F. Neurology 1983;
33:1444-52.
[4] Mori S., et
al. Neuroimage 2008;
40:570-82.
[5] Calhoun V., et al. Hum Brain Mapp
2001; 14:140-151.